George Barker
Healionics’ STARgraft receives US FDA Breakthrough Device designation
Healionics Corporation has today announced that its STARgraft arteriovenous graft—which it states is designed to provide a safer and more reliable means of bloodstream...
New study shows durability of minimally invasive procedure to combat knee...
A new study shows that a minimally invasive treatment for osteoarthritis (OA) in the knees may have a lasting benefit of at least two...
Merit Medical’s Wrapsody WAVE trial demonstrates superior patency versus standard of...
Merit Medical has today announced positive six-month findings from the randomised arteriovenous (AV) fistula arm of its Wrapsody Arteriovenous Access Efficacy (WAVE) pivotal trial....
12-month STRIDE data show high limb salvage rate and quality of...
One-year limb salvage and quality of life (QoL) data from the STRIDE study, showing that frontline use of Penumbra’s Indigo system for patients with...
Gelatin embolization efficacy data aims to lift regulatory embargo
“Yes, we know that gelatin sponge works, but I believe that these are vital data to show that what we do is safe and...
Money-maker or meritable: Is renal denervation out of retirement?
In a paper published in the July 2024 issue of the Journal of Hypertension, Andrew Sharp (University Hospital of Wales and Cardiff University, Cardiff,...
Thrombectomy gold rush set to follow ATTRACT study, experts argue
At the recent Endo Vascular Access (EVA) meeting (14–15 June, Patras, Greece), Ziv Haskal (University of Virginia School of Medicine, Charlottesville, USA) spoke to...
Shape Memory Medical advances endovascular embolisation by completing $38 million in...
Shape Memory Medical has announced that it has completed $38 million in Series C financing, which has been led by Earlybird Venture Capital, along...
